117 related articles for article (PubMed ID: 26701850)
21. TGFBR3 polymorphisms and its haplotypes associated with chronic hepatitis B virus infection and age of hepatocellular carcinoma occurrence.
Kim JH; Yu SJ; Park BL; Cheong HS; Pasaje CF; Bae JS; Lee HS; Shin HD; Kim YJ
Dig Dis; 2011; 29(3):278-83. PubMed ID: 21829018
[TBL] [Abstract][Full Text] [Related]
22. Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases.
Raimondo G; Costantino L; Caccamo G; Pollicino T; Squadrito G; Cacciola I; Brancatelli S
J Hepatol; 2004 Mar; 40(3):515-9. PubMed ID: 15123368
[TBL] [Abstract][Full Text] [Related]
23. A genetic variant of miR-335 binding site in the ERBB4 3'-UTR is associated with prognosis of ovary cancer.
Wei P; Li L; Zhang Z; Zhang W; Liu M; Sheng X
J Cell Biochem; 2018 Jul; 119(7):5135-5142. PubMed ID: 29125883
[TBL] [Abstract][Full Text] [Related]
24. Association of a microRNA-323b polymorphism with the persistence of hepatitis B virus infection by the enhancement of viral replication.
Yu SJ; Kim JW; Lee JH; Yoon JH; Lee HS; Cheong JY; Cho SW; Shin HD; Kim YJ
J Viral Hepat; 2014 Dec; 21(12):853-9. PubMed ID: 24341744
[TBL] [Abstract][Full Text] [Related]
25. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms.
Cheong JY; Cho SW; Hwang IL; Yoon SK; Lee JH; Park CS; Lee JE; Hahm KB; Kim JH
J Gastroenterol Hepatol; 2006 Jul; 21(7):1163-9. PubMed ID: 16824070
[TBL] [Abstract][Full Text] [Related]
26. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
[TBL] [Abstract][Full Text] [Related]
27. Potentially functional genetic variants in microRNA processing genes and risk of HBV-related hepatocellular carcinoma.
Liu L; An J; Liu J; Wen J; Zhai X; Liu Y; Pan S; Jiang J; Wen Y; Liu Z; Zhang Y; Chen J; Xing J; Ji G; Shen H; Hu Z; Fan Z
Mol Carcinog; 2013 Nov; 52 Suppl 1():E148-54. PubMed ID: 23868705
[TBL] [Abstract][Full Text] [Related]
28. The interferon receptor-1 promoter polymorphisms affect the outcome of Caucasians with HBeAg-negative chronic HBV infection.
Karamitros T; Papatheodoridis G; Dimopoulou E; Papageorgiou MV; Paraskevis D; Magiorkinis G; Sypsa V; Hatzakis A
Liver Int; 2015 Dec; 35(12):2506-13. PubMed ID: 25939635
[TBL] [Abstract][Full Text] [Related]
29. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development.
Hu L; Zhai X; Liu J; Chu M; Pan S; Jiang J; Zhang Y; Wang H; Chen J; Shen H; Hu Z
Hepatology; 2012 May; 55(5):1426-31. PubMed ID: 22105689
[TBL] [Abstract][Full Text] [Related]
30. Toll-like receptor 3 polymorphism and its association with hepatitis B virus infection in Saudi Arabian patients.
Al-Qahtani A; Al-Ahdal M; Abdo A; Sanai F; Al-Anazi M; Khalaf N; Viswan NA; Al-Ashgar H; Al-Humaidan H; Al-Suwayeh R; Hussain Z; Alarifi S; Al-Okail M; Almajhdi FN
J Med Virol; 2012 Sep; 84(9):1353-9. PubMed ID: 22825813
[TBL] [Abstract][Full Text] [Related]
31. Kupffer Cells Support Hepatitis B Virus-Mediated CD8+ T Cell Exhaustion via Hepatitis B Core Antigen-TLR2 Interactions in Mice.
Li M; Sun R; Xu L; Yin W; Chen Y; Zheng X; Lian Z; Wei H; Tian Z
J Immunol; 2015 Oct; 195(7):3100-9. PubMed ID: 26304988
[TBL] [Abstract][Full Text] [Related]
32. Correlation between polymorphisms in toll-like receptor genes and the activity of hepatitis B virus among treatment-naïve patients: a case-control study in a Han Chinese population.
Lin Y; Gao ZX; Shen X; Chen MJ; Li YT; Li SL; Lin HL; Zhao QF; Liu F; Niu JJ
BMC Infect Dis; 2018 Jan; 18(1):28. PubMed ID: 29320990
[TBL] [Abstract][Full Text] [Related]
33. Keratins 8 and 18 are type II acute-phase responsive genes overexpressed in human liver disease.
Guldiken N; Usachov V; Levada K; Trautwein C; Ziol M; Nahon P; Strnad P
Liver Int; 2015 Apr; 35(4):1203-12. PubMed ID: 24930437
[TBL] [Abstract][Full Text] [Related]
34. Use of RNA interference to modulate liver adenoma development in a murine model transgenic for hepatitis B virus.
Chen CC; Chang CM; Sun CP; Yu CP; Wu PY; Jeng KS; Hu CP; Chen PJ; Wu JC; Shih CH; Gershwin ME; Tao MH
Gene Ther; 2012 Jan; 19(1):25-33. PubMed ID: 21562593
[TBL] [Abstract][Full Text] [Related]
35. [Establishment of hepatitis B virus (HBV) chronic infection mouse model by in vivo transduction with a recombinant adeno-associated virus 8 carrying 1. 3 copies of HBV genome (rAAN8-1. 3HBV)].
Dong XY; Yu CJ; Wang G; Tian WH; Lu Y; Zhang FW; Wang W; Wang Y; Tan WJ; Wu XB
Bing Du Xue Bao; 2010 Nov; 26(6):425-31. PubMed ID: 21344744
[TBL] [Abstract][Full Text] [Related]
36. Host genetic variants influencing the clinical course of hepatitis B virus infection.
Matsuura K; Isogawa M; Tanaka Y
J Med Virol; 2016 Mar; 88(3):371-9. PubMed ID: 26255971
[TBL] [Abstract][Full Text] [Related]
37. Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels.
Pollicino T; Amaddeo G; Restuccia A; Raffa G; Alibrandi A; Cutroneo G; Favaloro A; Maimone S; Squadrito G; Raimondo G
Hepatology; 2012 Aug; 56(2):434-43. PubMed ID: 22271491
[TBL] [Abstract][Full Text] [Related]
38. HLA-DP and γ-interferon receptor-2 gene variants and their association with viral hepatitis activity in chronic hepatitis B infection.
Lam YF; Wong DK; Seto WK; To KK; Hung IF; Fung J; Lai CL; Yuen MF
J Gastroenterol Hepatol; 2014 Mar; 29(3):533-9. PubMed ID: 23980639
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of death pathway genes FAS and FASL polymorphisms in chronic HBV infection.
Zamani AG; Barlas IO; Durakbasi-Dursun G; Ural O; Erdal E; Yildirim MS
Int J Immunogenet; 2013 Dec; 40(6):482-7. PubMed ID: 23560484
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the complete hepatitis B virus genome in patients with genotype C chronic hepatitis in relation to HBeAg and anti-HBe.
Zhang K; Imazeki F; Fukai K; Arai M; Kanda T; Mikata R; Yokosuka O
J Med Virol; 2007 Jun; 79(6):683-93. PubMed ID: 17457922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]